These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 14765378)

  • 1. Factors influencing survival in high-grade gliomas.
    Buckner JC
    Semin Oncol; 2003 Dec; 30(6 Suppl 19):10-4. PubMed ID: 14765378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials.
    Curran WJ; Scott CB; Horton J; Nelson JS; Weinstein AS; Fischbach AJ; Chang CH; Rotman M; Asbell SO; Krisch RE
    J Natl Cancer Inst; 1993 May; 85(9):704-10. PubMed ID: 8478956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recursive partitioning analysis of prognostic factors in WHO grade III glioma patients treated with radiotherapy or radiotherapy plus chemotherapy.
    Park CK; Lee SH; Han JH; Kim CY; Kim DW; Paek SH; Kim DG; Heo DS; Kim IH; Jung HW
    BMC Cancer; 2009 Dec; 9():450. PubMed ID: 20017960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic value of clinical factors and cancer stem cell-related markers in gliomas.
    Dahlrot RH
    Dan Med J; 2014 Oct; 61(10):B4944. PubMed ID: 25283629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and Molecular Recursive Partitioning Analysis of High-grade Glioma Treated With IMRT.
    Sutera P; Kalash R; Flickinger J; Engh J; Heron DE
    Am J Clin Oncol; 2019 Jan; 42(1):27-35. PubMed ID: 29912004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors for low-grade gliomas.
    Stupp R; Janzer RC; Hegi ME; Villemure JG; Mirimanoff RO
    Semin Oncol; 2003 Dec; 30(6 Suppl 19):23-8. PubMed ID: 14765381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognostic factors in malignant gliomas].
    Ushio Y; Kochi M
    Gan To Kagaku Ryoho; 1996 Apr; 23(5):643-8. PubMed ID: 8678527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretreatment factors predict overall survival for patients with low-grade glioma: a recursive partitioning analysis.
    Bauman G; Lote K; Larson D; Stalpers L; Leighton C; Fisher B; Wara W; MacDonald D; Stitt L; Cairncross JG
    Int J Radiat Oncol Biol Phys; 1999 Nov; 45(4):923-9. PubMed ID: 10571199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supratentorial anaplastic gliomas in adults. The prognostic importance of extent of resection and prior low-grade glioma.
    Winger MJ; Macdonald DR; Cairncross JG
    J Neurosurg; 1989 Oct; 71(4):487-93. PubMed ID: 2552044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of adjuvant treatments on survival in Korean patients with WHO grade II gliomas: KNOG 15-02 and KROG 16-04 intergroup study.
    Koo T; Lim DH; Seol HJ; Dho YS; Kim IH; Chang JH; Lee J; Jung TY; Gwak HS; Cho KH; Hong CK; Lee IJ; Kim E; Kim JH; Hong YK; Jang HS; Kim CY; Kim IA; Kim SH; Kim YI; Kim EY; Kim WC; Hong S
    J Neurooncol; 2018 Nov; 140(2):445-455. PubMed ID: 30097825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is less more? Comparing chemotherapy alone with chemotherapy and radiation for high-risk grade 2 glioma: An analysis of the National Cancer Data Base.
    Jhaveri J; Liu Y; Chowdhary M; Buchwald ZS; Gillespie TW; Olson JJ; Voloschin AD; Eaton BR; Shu HG; Crocker IR; Curran WJ; Patel KR
    Cancer; 2018 Mar; 124(6):1169-1178. PubMed ID: 29205287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic, treatment, and demographic factors influencing survival in a population-based study of adult glioma patients in the San Francisco Bay Area.
    Wrensch M; Rice T; Miike R; McMillan A; Lamborn KR; Aldape K; Prados MD
    Neuro Oncol; 2006 Jan; 8(1):12-26. PubMed ID: 16443944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oligodendroglial tumors: refinement of candidate regions on chromosome arm 1p and correlation of 1p/19q status with survival.
    Felsberg J; Erkwoh A; Sabel MC; Kirsch L; Fimmers R; Blaschke B; Schlegel U; Schramm J; Wiestler OD; Reifenberger G
    Brain Pathol; 2004 Apr; 14(2):121-30. PubMed ID: 15193024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic implication of clinical, radiologic, and pathologic features in patients with anaplastic gliomas.
    Tortosa A; Viñolas N; Villà S; Verger E; Gil JM; Brell M; Caral L; Pujol T; Acebes JJ; Ribalta T; Ferrer I; Graus F
    Cancer; 2003 Feb; 97(4):1063-71. PubMed ID: 12569607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long survival and therapeutic responses in patients with histologically disparate high-grade gliomas demonstrating chromosome 1p loss.
    Ino Y; Zlatescu MC; Sasaki H; Macdonald DR; Stemmer-Rachamimov AO; Jhung S; Ramsay DA; von Deimling A; Louis DN; Cairncross JG
    J Neurosurg; 2000 Jun; 92(6):983-90. PubMed ID: 10839259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between chromosome 1p/19q status and VEGF mRNA expression in gliomas.
    Yang B; Hao XQ; Zeng XW; Ji TL; Pan S; Feng YG
    Genet Mol Res; 2016 Jan; 15(1):. PubMed ID: 26909925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-grade gliomas of the cerebral hemispheres in children: an analysis of 71 cases.
    Pollack IF; Claassen D; al-Shboul Q; Janosky JE; Deutsch M
    J Neurosurg; 1995 Apr; 82(4):536-47. PubMed ID: 7897512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment Outcomes in 1p19q Co-deleted/Partially Deleted Gliomas.
    McNamara MG; Jiang H; Lim-Fat MJ; Sahebjam S; Kiehl TR; Karamchandani J; Coire C; Chung C; Millar BA; Laperriere N; Mason WP
    Can J Neurol Sci; 2017 May; 44(3):288-294. PubMed ID: 28488951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of EORTC prognostic factors for adults with low-grade glioma: a report using intergroup 86-72-51.
    Daniels TB; Brown PD; Felten SJ; Wu W; Buckner JC; Arusell RM; Curran WJ; Abrams RA; Schiff D; Shaw EG
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):218-24. PubMed ID: 21549518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extent of resection, molecular signature, and survival in 1p19q-codeleted gliomas.
    Garton ALA; Kinslow CJ; Rae AI; Mehta A; Pannullo SC; Magge RS; Ramakrishna R; McKhann GM; Sisti MB; Bruce JN; Canoll P; Cheng SK; Sonabend AM; Wang TJC
    J Neurosurg; 2021 May; 134(5):1357-1367. PubMed ID: 32384274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.